biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	202C1A31-6449-4547-BDC8-E5DD1DE33113
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-2Y-A9GU-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-2Y-A9GU-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-2Y-A9GU-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104744
biospecimen__bio__day_of_creation	14
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-2Y-A9GU.5585C485-B57A-4CA8-A3E3-F093A7E6AC76.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	E
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-2Y-A9GU
biospecimen__shared__patient_id	A9GU
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	B0C26553-D83F-4938-8529-2031AA52EB37
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.4
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.3
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	304
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	11.5
clinical__chol_lihc_shared__platelet_result_lower_limit	143
clinical__chol_lihc_shared__platelet_result_upper_limit	382
clinical__chol_lihc_shared__prothrombin_time_result_value	10.8
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__clin_shared__age_at_initial_pathologic_diagnosis	55
clinical__clin_shared__bcr_followup_barcode	TCGA-2Y-A9GU-F69082
clinical__clin_shared__bcr_followup_uuid	FB05E6D4-A090-475A-92A3-DED79D7B91FA
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	281
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	6b4610e6-a85c-4cf1-87f1-750b332c9bf4
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-2Y-A9GU-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	2230d767-45a9-4f29-846a-f347a1139542
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.84
gdc__analytes__analyte_id	4e54e9f5-75ab-4990-a849-d784375ce2ef
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	b27720a2-e240-413c-a0f1-0b1af3621de2
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	0250e97f-8d78-55a2-919c-4e7e1884c932
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1954
gdc__diagnoses__age_at_diagnosis	20187
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-20187.0
gdc__diagnoses__days_to_last_follow_up	1939.0
gdc__diagnoses__diagnosis_id	da49717f-e4d6-55bb-9760-573c3dae1b56
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	32.889188733344575
gdc__exposures__exposure_id	14cc9bdd-bab7-52d1-ba3b-bb0e37b13c68
gdc__exposures__height	154.0
gdc__exposures__weight	78.0
gdc__file_id	8f2447b4-238d-4fe0-b815-ced58465cc94
gdc__file_name	8ca147a7-72f8-4f1a-97ee-83d7f056ed0a.mirbase21.mirnas.quantification.txt
gdc__file_size	50199
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	ec3a79f4e7a61becb82d6dc1f69d99cf
gdc__portions__is_ffpe	false
gdc__portions__portion_id	b00d0686-306b-4818-ada8-f5614a5519fc
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1752
gdc__samples__initial_weight	120.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	5585C485-B57A-4CA8-A3E3-F093A7E6AC76
gdc__samples__sample_id	6477af21-e833-4b46-8658-5da593030fed
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	7018ccf5-3126-497f-81df-c5c0fdc86f05
gdc__submitter_id	mirna_swap_dr11_159_MirnaExpression5b5f68a4-6298-4388-8770-78ad4eb86796_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	2Y
gdc__tissue_source_site__name	Moffitt Cancer Center
gdc__tissue_source_site__tissue_source_site_id	33e340f9-a97a-56eb-a3e6-aad831681cb4
gdc__treatments__treatment_id	e7822130-c7a8-5b25-b4ab-889e2d15c206
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:02.786+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/6b4610e6-a85c-4cf1-87f1-750b332c9bf4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/6b4610e6-a85c-4cf1-87f1-750b332c9bf4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129570
manually_curated__local_md5	d5c3bb069e04202afbb2b6fbd237a43f
manually_curated__opengdc_download_date	2018-10-16T17:10:01.000709+02:00
manually_curated__opengdc_file_md5	7a2b5131625166415f60cec58091bfd7
manually_curated__opengdc_file_size	50198
manually_curated__opengdc_id	6b4610e6-a85c-4cf1-87f1-750b332c9bf4-meq
manually_curated__origin_file_size	129570
manually_curated__origin_last_modified_date	Tue Oct 16 17:45:00 CEST 2018
manually_curated__origin_md5	d5c3bb069e04202afbb2b6fbd237a43f
manually_curated__tissue_status	tumoral
